Chronic Lyme disease: In defense of the scientific enterprise

FASEB Journal

Volumn 24, Issue 11, 2010, Pages 4175-4177

  Baker, Phillip J ^a  

^a American Lyme Disease Foundation   (United States)

Author keywords

Antibiotic therapy; Evidence based research

Indexed keywords

ANTIBIOTIC AGENT; GABAPENTIN; PREGABALIN;

ANTIBIOTIC THERAPY; BORRELIA BURGDORFERI; DRUG SAFETY; FIBROMYALGIA; GOVERNMENT; HEALTH STATUS; HUMAN; IMMUNE RESPONSE; LEGAL ASPECT; LYME DISEASE; MEDICAL PRACTICE; MEDICAL RESEARCH; NONHUMAN; POPULATION; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; BIOMEDICAL RESEARCH; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; INSURANCE, HEALTH; LYME DISEASE; TIME FACTORS;

EID: 78649814423     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-167247     Document Type: Review

References (19)

1. Weissmann, G. (2007) "Chronic Lyme" disease and other medically unexplained syndromes. FASEB J. 21, 299-301
2. Klempner, M. S., Hu, L., Evans, J., Schmid, C. H., Johnson, G. M., Trevino, R. P., Norton, D., Levy, L., Wall, D., Kosinski, M., and Weinstein, A. (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. New Eng. J. Med. 345, 85-92
3. Krupp, L. B., Hyman, L. G., Grimson, R., Coyle, P. K., Melville, P., Dattwyler, A. S., and Chandler, B. (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double-masked clinical trial. Neurology 60, 1923-1930
4. Fallon, B. A., Keilp, J. G., Corber, K. M., Petkova, E., Britton, C. B., Dwyer, E., Slavov, I., Cheng, J., Dobkin, J., Nelson, D. R., and Sackheim, H. A. (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70, 992-1003
5. Sigal, L. H. (2007) Misconceptions about Lyme disease: confusions hiding behind ill-chosen terminology. Ann. Intern. Med. 120, S4-S25
6. Domercq, M., and Matute, C. (2004) Neuroprotection by tetracyclines. Trends Pharmacol. Sci. 25, 609-612
7. Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Cheng, D. S., Toan, S. V., Bruijn, L.I., Su, Z. Z., Gupta, P., and Fisher, P. B. (2005) β-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 73-77
8. Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, J. S., and Nadelman, R. B. (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43, 1089-1134
9. Kraemer, J. D., and Gostlin, L. O. (2009) Science, politics, and values. JAMA 301, 665-667
10. Lantos, P. M., Charini, W. A., Medoff, G., Moro, M. H., Mushatt, D. M., Parsonnet, J., Sanders, J. W., and Baker, C. J. (2010). Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin. Infect. Dis. 51, 1-5
11. Mygland, A., Ljostad, U., Fingerle, V., Rupprecht, T., Schmutzhard, E., and Steiner, I. (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Euro. J. Neurol. 17, 8-16
12. European Union concerted action on Lyme borreliosis. http:// meduni09.edis.at/eucalb/cms/index.php?lang=en
13. Halperin, J. J., Shapiro, E. D., Logigian, E., Belman, A. L., Dotevall, L., Wormser, G. P., Krupp, L., Gronseth, G., and Bever, C. T. Jr. (2007) Practice parameter: treatment of nervous system Lyme disease (as evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 69, 91-102
14. Canadian Public Health Network, The laboratory diagnosis of Lyme borreliosis: guidelines from the Canadian Public Health Laboratory Network. (2007) Can. J. Infect. Dis. Med. Microbiol. 18, 145-148
15. Nau, R., Christen, H., and Effert, H. (2009) Lyme disease - current state of knowledge. Dtsch. Arztebl. Int. 106, 72-81
16. Baker, P. J. (2008) Perspectives on "chronic Lyme disease". Am. J. Med. 121, 562-564
17. Weissenbacher, G. P., Ring, J., and Hofman, H. (2005) Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage Lyme borreliosis: a pilot study. Dermatology 211, 123-127
18. Hassett, A., Radvanski, D. C., Buyske, S., Savage, S. V., Gara, M., Escobar, J. I., and Sigal, L. H. (2009) Role of psychiatric comorbidity in chronic Lyme disease. Arthritis Rheum. 59, 1742-1749
19. Chandra, A., Wormser, G. P., Klempner, M. S., Trevino, R. P., Crow, M. K., Latov, N., and Alaedini, A. (2010) Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav. Immun. 24, 1018-1024